Pfizer Inc. Q2 Profit Increases, Beats Estimates; 2022 Outlook Below View - Update

(Adds Outlook)

Pfizer Inc. (PFE) announced earnings for its second quarter that increased from last year and beat the Street estimates.

The company's earnings came in at $9.91 billion, or $1.73 per share. This compares with $5.56 billion, or $0.98 per share, in last year's second quarter.

Excluding items, Pfizer Inc. reported adjusted earnings of $11.66 billion or $2.04 per share for the period.

Analysts on average had expected the company to earn $1.80 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 46.8% to $27.74 billion from $18.90 billion last year.


For fiscal 20220, Pfizer edged up its earnings guidance to $6.30- $6.45 a share from its earlier view of $6.25 - $6.45 a share.

The company also reiterated revenue outlook of $98 billion-$102.0 billion

Analysts on average expect the company to earn $6.62 per share on revenue of $102.92 billion.

Pfizer Inc. earnings at a glance (GAAP) :

-Earnings (Q2): $9.91 Bln. vs. $5.56 Bln. last year.
-EPS (Q2): $1.73 vs. $0.98 last year.
-Analyst Estimate: $1.80
-Revenue (Q2): $27.74 Bln vs. $18.90 Bln last year.

Full year EPS guidance: $6.30 to $6.45
Full year revenue guidance: $98.0 - $102.0 Bln

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT